Economic evaluation of cefuroxime sodium powder-liquid dual-chamber bags for perioperative patients from the hospital perspective
- VernacularTitle:医院视角下头孢呋辛钠粉液双室袋用于围手术期患者的经济学研究
- Author:
Haijing GUAN
1
;
Zhigang ZHAO
1
;
Changsheng FAN
2
Author Information
1. Dept. of Pharmacy，Beijing Tiantan Hospital，Capital Medical University，Beijing 100070，China
2. Beijing Medical and Health Economic Research Association，Beijing 100069，China
- Publication Type:Journal Article
- Keywords:
cefuroxime;
powder-liquid dual-chamber bag;
powder injection;
perioperative period;
economics;
medical
- From:
China Pharmacy
2025;36(4):454-458
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To evaluate the possible effects of Cefuroxime sodium for injection/Sodium chloride injection （referred to as “Cefuroxime powder-liquid dual-chamber bag”） or Cefuroxime sodium for injection （referred to as “Cefuroxime powder injection”） used in perioperative patients on hospital costs under the background of medical insurance payment reform from the perspective of the hospital. METHODS Assuming that the effectiveness and safety of Cefuroxime powder-liquid dual-chamber bag （scenario 1） and Cefuroxime powder injection （scenario 2） were the same for perioperative patients， the cost-effectiveness of both scenarios was compared by calculating the costs of drug， infusion sets， and labor in the pharmacy intravenous admixture service. The robustness of the results was explored through univariate sensitivity analysis and different centralized procurement share scenarios analysis. RESULTS The base-case analysis showed that the average cost per treatment course for patients using cefuroxime in scenario 1 and scenario 2 were 314.54 yuan and 349.41 yuan， respectively， meaning scenario 1 saved 34.87 yuan per capita compared to scenario 2. The univariate sensitivity analysis and scenario analysis indicated that the research results were robust. CONCLUSIONS The application of Cefuroxime powder-liquid dual-chamber bag in perioperative patients can save medical costs while ensuring the quality and efficiency of medical services， compared to Cefuroxime powder injection.
